Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ)
CNY 10.45
(0.1%)
CNY 10.45
(0.1%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 141.6 Million CNY | -50.09% |
| 2022 | 293.38 Million CNY | 21.05% |
| 2021 | 240.75 Million CNY | -0.26% |
| 2020 | 242.59 Million CNY | 6.77% |
| 2019 | 226.07 Million CNY | -15.89% |
| 2018 | 291.86 Million CNY | 12.77% |
| 2017 | 241.65 Million CNY | 128.47% |
| 2016 | 112.03 Million CNY | 43.36% |
| 2015 | 66.38 Million CNY | -15.23% |
| 2014 | 83.98 Million CNY | 61.91% |
| 2013 | 58.12 Million CNY | -43.17% |
| 2012 | 101.5 Million CNY | 17.49% |
| 2011 | 97.44 Million CNY | 33.43% |
| 2010 | 65.02 Million CNY | -24.92% |
| 2009 | 85.7 Million CNY | -31.86% |
| 2008 | 127.54 Million CNY | 53.67% |
| 2007 | 81.79 Million CNY | 103.54% |
| 2006 | 40.77 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 27.22 Million CNY | -55.14% |
| 2024 Q1 | 31.9 Million CNY | 286.06% |
| 2024 Q3 | 8.01 Million CNY | -70.37% |
| 2023 Q1 | 4.89 Million CNY | -71.11% |
| 2023 Q2 | 45.89 Million CNY | 837.98% |
| 2023 Q3 | 6.19 Million CNY | -86.49% |
| 2023 FY | - CNY | -50.09% |
| 2023 Q4 | -85.6 Million CNY | -1480.8% |
| 2022 Q2 | 73.23 Million CNY | 23.08% |
| 2022 Q3 | 46.19 Million CNY | -36.92% |
| 2022 Q4 | 16.93 Million CNY | -63.34% |
| 2022 Q1 | 59.5 Million CNY | 64.64% |
| 2022 FY | - CNY | 21.05% |
| 2021 Q4 | 36.13 Million CNY | -21.78% |
| 2021 Q1 | 12.71 Million CNY | 68.58% |
| 2021 Q2 | 52.91 Million CNY | 316.02% |
| 2021 Q3 | 46.2 Million CNY | -12.69% |
| 2021 FY | - CNY | -0.26% |
| 2020 FY | - CNY | 6.77% |
| 2020 Q2 | 107.5 Million CNY | 1225.78% |
| 2020 Q1 | 8.1 Million CNY | -86.46% |
| 2020 Q4 | 7.54 Million CNY | -76.95% |
| 2020 Q3 | 32.73 Million CNY | -69.55% |
| 2019 Q2 | 30.69 Million CNY | 491.14% |
| 2019 FY | - CNY | -15.89% |
| 2019 Q4 | 59.88 Million CNY | 51.6% |
| 2019 Q3 | 39.49 Million CNY | 28.7% |
| 2019 Q1 | 5.19 Million CNY | -90.11% |
| 2018 Q3 | 43.62 Million CNY | -37.1% |
| 2018 FY | - CNY | 12.77% |
| 2018 Q1 | 58.19 Million CNY | 17.02% |
| 2018 Q2 | 69.35 Million CNY | 19.18% |
| 2018 Q4 | 52.48 Million CNY | 20.32% |
| 2017 Q2 | 62.98 Million CNY | 145.27% |
| 2017 Q1 | 25.67 Million CNY | 451.87% |
| 2017 FY | - CNY | 128.47% |
| 2017 Q4 | 49.73 Million CNY | -19.49% |
| 2017 Q3 | 61.77 Million CNY | -1.93% |
| 2016 FY | - CNY | 43.36% |
| 2016 Q4 | 4.65 Million CNY | -65.41% |
| 2016 Q3 | 13.45 Million CNY | -26.67% |
| 2016 Q2 | 18.34 Million CNY | 143.1% |
| 2016 Q1 | 7.54 Million CNY | 385.12% |
| 2015 Q2 | 8.97 Million CNY | 301.44% |
| 2015 Q1 | 2.23 Million CNY | -59.86% |
| 2015 Q3 | 1.43 Million CNY | -84.04% |
| 2015 FY | - CNY | -15.23% |
| 2015 Q4 | -2.64 Million CNY | -284.76% |
| 2014 Q2 | 21.57 Million CNY | 3595.71% |
| 2014 Q1 | -617.04 Thousand CNY | 65.1% |
| 2014 FY | - CNY | 61.91% |
| 2014 Q4 | 5.57 Million CNY | -53.34% |
| 2014 Q3 | 11.93 Million CNY | -44.65% |
| 2013 FY | - CNY | -43.17% |
| 2013 Q4 | -1.76 Million CNY | -144.93% |
| 2013 Q2 | 6.85 Million CNY | -21.45% |
| 2013 Q3 | 3.93 Million CNY | -42.57% |
| 2013 Q1 | 8.72 Million CNY | -61.94% |
| 2012 FY | - CNY | 17.49% |
| 2012 Q2 | 24.88 Million CNY | 48.78% |
| 2012 Q3 | 18.79 Million CNY | -24.46% |
| 2012 Q4 | 22.92 Million CNY | 21.95% |
| 2012 Q1 | 16.72 Million CNY | 12.34% |
| 2011 Q3 | 18.55 Million CNY | -33.19% |
| 2011 Q2 | 27.76 Million CNY | 195.52% |
| 2011 Q1 | 9.39 Million CNY | -45.59% |
| 2011 FY | - CNY | 33.43% |
| 2011 Q4 | 14.88 Million CNY | -19.74% |
| 2010 Q4 | 17.27 Million CNY | 60.16% |
| 2010 FY | - CNY | -24.92% |
| 2010 Q3 | 10.78 Million CNY | 112.3% |
| 2010 Q2 | 5.07 Million CNY | -72.86% |
| 2010 Q1 | 18.71 Million CNY | -24.36% |
| 2009 Q1 | 15.05 Million CNY | 0.0% |
| 2009 Q3 | 15.13 Million CNY | -28.94% |
| 2009 Q2 | 21.3 Million CNY | 41.54% |
| 2009 Q4 | 24.73 Million CNY | 63.39% |
| 2009 FY | - CNY | -31.86% |
| 2008 FY | - CNY | 53.67% |
| 2007 FY | - CNY | 103.54% |
| 2006 FY | - CNY | 0.0% |